Immunogenic polypeptides having the capability to precipitate and focus a
CpG adjuvant exhibit enhanced in vivo priming of a cytotoxic T-lymphocyte
(CTL) response. Accordingly, compositions that include a bipartite
immunogenic polypeptide are provided herein. The bipartite polypeptide
includes a CpG-interacting amino acid sequence and a CTL-activating amino
acid sequence. Also provided are methods of identifying and using a
bipartite immunogenic polypeptide.